Lactate's harmful epigenetic signaling in vascular inflammation is facilitated by its influx through MCT1, suggesting the possibility of mitigating vascular inflammation by selectively targeting MCT1 activity in the context of atherosclerosis. Here, SLC16A1 is linked to atherosclerosis.